Table 1. Description of the Sample Sets in the Current Study.

Genotyping Stage	Genotyped SNPs, No.	Disease Status	Participants, No.	Male, No./Female, No.	Age at Examination, Mean (SD), y
Discovery	2 752 055	GD with TPP	175	164/11	34 (11)
		Control	2160	601/1559	45 (9)
		GD without TPP	1519	366/1153	38 (13)
Replication	134	TPP	362	294/68	35 (11)
		Control	1089	1047/42	48 (12)
Combined	134	TPP	537	458/79	35 (11)
		Control	3249	1648/1601	46 (10)

Abbreviations: GD, Graves disease; SNP, single-nucleotide polymorphism; TPP, thyrotoxic periodic paralysis.